Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Maltose API Manufacturers & Suppliers
1 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
All certificates
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Maltose | CAS No: 69-79-4 | GMP-certified suppliers
A medication that provides a metabolizable carbohydrate source supporting energy metabolism, primarily used in food and industrial applications rather than direct clinical treatment.
Therapeutic categories
Product Snapshot
- Maltose is available as an injectable intravenous formulation
- It is primarily used for experimental and investigational purposes in various therapeutic applications
- Maltose has not received approval from major regulatory agencies such as the FDA or EMA
Clinical Overview
There are no clinically approved therapeutic indications for maltose as an active pharmaceutical ingredient. Its primary applications are found in the food industry, particularly as a sweetening agent and a fermentable substrate in brewing and food production processes. Maltose is commonly utilized in research and industrial settings rather than in direct clinical use.
Pharmacologically, maltose is metabolized in the human body through hydrolysis mediated by maltase enzymes located in the small intestine. This enzymatic activity cleaves maltose into two glucose molecules, which are subsequently absorbed into the bloodstream. The glucose derived from maltose contributes to normal carbohydrate metabolism, being available for cellular energy processes.
Key absorption, distribution, metabolism, and excretion (ADME) characteristics include rapid intestinal hydrolysis with resultant glucose absorption. Maltose itself does not exhibit systemic pharmacodynamic effects, as it is primarily a nutritional carbohydrate rather than a pharmacologically active agent.
Safety and toxicity profiles are consistent with those of digestible sugars; maltose is generally regarded as safe when ingested in normal dietary quantities. There is limited data on maltose-related adverse effects beyond typical concerns related to excessive carbohydrate intake such as glycemic control.
Prominent usage contexts for maltose include food manufacturing and fermentation industries, where it serves specific functional roles. The substance is classified as experimental or investigational in pharmaceutical contexts, reflecting limited direct clinical use.
From an API sourcing perspective, maltose manufacturing requires stringent quality control to ensure purity, consistent glycosidic linkage, and absence of contaminants. Compliance with pharmacopeial standards for carbohydrate APIs is crucial when used in formulations or excipient roles to meet regulatory and safety requirements.
Identification & chemistry
| Generic name | Maltose |
|---|---|
| Molecule type | Small molecule |
| CAS | 69-79-4 |
| UNII | 66Y63L379N |
| DrugBank ID | DB03323 |
Pharmacology
Targets
| Target | Organism | Actions |
|---|---|---|
| Cyclomaltodextrin glucanotransferase | Bacillus circulans | |
| Alpha-amylase 2B | Humans | |
| Beta-amylase | Bacillus cereus |
Formulation & handling
- Maltose is a small molecule with high water solubility suitable for intravenous injection formulations.
- Due to its negative LogP, it exhibits hydrophilic properties and should be handled with aqueous systems.
- As an O-glycosyl compound, maltose stability may require control of moisture and temperature to prevent degradation.
Regulatory status
Maltose is a type of Indifferent resources
Indifferent resources, in the context of pharmaceutical active pharmaceutical ingredients (APIs), refer to the subcategory of materials used in the manufacturing process that do not react with or significantly affect the chemical properties of the API. These resources play a crucial role in ensuring the purity and stability of the final pharmaceutical product.
Indifferent resources include solvents, excipients, catalysts, and other auxiliary substances used during API synthesis or formulation. They are carefully selected to have minimal reactivity with the API, preserving its chemical integrity and therapeutic efficacy. The choice of indifferent resources depends on factors such as the API's chemical structure, solubility, and stability requirements.
By employing indifferent resources, pharmaceutical manufacturers can mitigate the risk of unwanted chemical reactions or degradation during the production and storage of APIs. This, in turn, enhances the quality and reliability of the pharmaceutical product.
In the pharmaceutical industry, the selection and use of indifferent resources are critical in complying with regulatory guidelines and ensuring the safety and efficacy of medications. Manufacturers must adhere to Good Manufacturing Practices (GMP) and perform comprehensive compatibility studies to identify suitable indifferent resources for their specific APIs.
Overall, indifferent resources serve as indispensable components in the pharmaceutical API manufacturing process, guaranteeing the production of high-quality, stable, and safe medications that meet stringent regulatory standards.
Maltose (Indifferent resources), classified under Others
The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.
Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.
The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.
Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.
In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.
Maltose API manufacturers & distributors
Compare qualified Maltose API suppliers worldwide. We currently have 1 companies offering Maltose API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| Ferro Pfanstiehl Labs. | Producer | United States | United States | CoA, USDMF | 6 products |
When sending a request, specify which Maltose API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality Maltose API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
